Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →A patent landscape review of sequencing read and genomic data compression algorithms: filing trends since 2015, the leading assignee, technology composition across eight IPC subclasses, and where claim space remains open
Filing growth = 2021 (23 records) → 2024 (1); 2024 is the last year we treat as complete.
This landscape draws on 74 published records matching sequencing read or genomic data compression algorithms, filed between 2015 and the 2026 data cut-off. It maps who is filing, what technical ground the claims occupy across eight IPC subclasses, and how filing activity has moved since the field's early years. The dataset treats each record as a patent family, which is the fairer counting unit because it neutralises repeat continuation filings and multi-jurisdiction duplicates of the same invention.
Coverage runs from a single 2011 filing through a 2021 peak of 23 records, tapering toward the present. Because publication typically lags filing by around 18 months, the most recent one to two years in any trend chart are undercounts, not necessarily a real drop-off in inventive activity.
Pick a task. Every answer cites the patents behind it.
Two views of the same 74-record dataset: how filing activity has moved year over year, and which technical classes the claims actually sit in.
Filings rose from a single record in 2011 to a peak of 23 in 2021, then declined to 1 by 2024 -- a -96% move the evidence supports directly. Because publications take roughly 18 months to appear after filing, 2025 and 2026 figures are not yet complete and should not be read as confirmation the field has gone quiet.
Publication lags filing by roughly 18 months, so 2025 onwards are still filling in. Growth rates on this page therefore end at 2024; running them to the last bar would understate the field.
G16B (bioinformatics) appears on 83.8% of the 74 records and G06F (digital data processing) on 50.0%, meaning most claims are written as bioinformatics or computing workflows rather than pure compression method. Dedicated coding and code-conversion class H03M covers just 10.8%, and adjacent classes -- C12Q at 14.9%, H04L at 5.4%, A61B and H04N each at 4.1%, and G01N at 2.7% -- show where the technique intersects sequencing hardware, transmission and diagnostics without being the primary claim focus there.
Shares are the percentage of the 74 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
This page is one run against one query. Ask Eureka your own question about sequence read compression algorithm patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaThe filing describes a method for storing a genomic dataset within a file structure paired with an information metadata structure -- covering annotation tables with user profile and permission data, analytics information to verify data reproducibility, access history for traceability, and linkage information tying the annotation table to the underlying dataset.Abstract text shown as published; reference numerals from the original drawing are retained.


When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Three figures from this dataset carry more decision-relevant weight than the raw record count: the gap at the top of the ranking, the shape of the filing curve, and the split between bioinformatics and generic coding claims.
The leading assignee holds 32 records against 3 at fifth place and 2 at tenth, in a ranking of 18 companies and inventors. That gap suggests one organisation built an early, broad filing position while the rest of the field holds narrower, more scattered claims.
Filings climbed to a peak of 23 records in 2021 before falling to 1 by 2024, a -96% move over that three-year span. Because publication lags filing by around 18 months, 2025-2026 counts are still incomplete and should not be read as evidence the field has stopped moving.
G16B appears on 83.8% of the 74 records in scope, while dedicated coding and code-conversion class H03M covers just 10.8%. Most applicants are claiming the compression step as part of a genomic data pipeline rather than as a standalone codec, which shapes where a freedom-to-operate search needs to look first.
The United States received 19 filings, EPO 12, WIPO/PCT 11, India 10, Israel 8 and Australia 6. The PCT and India counts suggest applicants are routing a meaningful share of these filings toward broader or emerging-market coverage rather than concentrating solely on the US and Europe.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to sequence read compression algorithm patent landscape, with the prior art for and against each one.
The dataset points to a field with one entrenched filer, a filing curve still filling in for recent years, and claim territory concentrated in bioinformatics workflow rather than generic coding. The next steps depend on whether the goal is freedom-to-operate, licensing, or identifying where to file next.
A 32-record filer with this kind of gap over the rest of the ranking is worth a claim-by-claim read, not just a count. Understanding exactly what is claimed narrows where new filings can safely sit.
Explore the leader's portfolio in EurekaCoding-class and transmission-class overlaps sit well below the bioinformatics share, at 10.8% and 5.4% of the 74 records respectively. That gap is where a compression-first claim, rather than a workflow claim, may still have room.
Run a white-space search in EurekaThe 2024 figure is the last complete year; 2025 and 2026 will keep filling in as filings publish. Re-checking this trend in six to twelve months will show whether the 2021 peak was a one-off cycle or the start of a longer plateau.
Set an alert in EurekaOne assignee leads the ranking with 32 records, well ahead of the fifth-placed entrant at 3 and the tenth at 2, across an 18-company ranking. That gap indicates an early, broad filing position rather than a fragmented field, though 17 other companies and inventors still hold active families. Anyone doing freedom-to-operate work in this space should start with the leader's portfolio before looking at the long tail.
Filings peaked at 23 records in 2021 and fell to 1 by 2024, a decline the evidence states as -96% over that three-year span. That drop is real for the years it covers, but publication typically lags filing by about 18 months, so 2025 and 2026 counts are still incomplete and should not be read as proof the field has gone quiet. A fair re-read of the trend needs another year or two of publications to land.
The dominant class is G16B, bioinformatics, appearing on 83.8% of the 74 records in scope, followed by G06F, digital data processing, at 50.0%. Dedicated coding and code-conversion class H03M covers only 10.8%, with smaller overlaps into DNA measurement (C12Q, 14.9%), digital transmission (H04L, 5.4%), diagnosis and surgery (A61B, 4.1%), pictorial communication (H04N, 4.1%) and material analysis (G01N, 2.7%). Because a record can carry multiple classes, these shares add to more than 100%, and the pattern shows claims framed mostly as bioinformatics workflow rather than as generic compression method.
The densest claim territory sits in G16B bioinformatics workflow claims at 83.8% of the 74 records, so a narrowly workflow-framed claim is more likely to run into prior art there. The comparatively thin H03M coding class, at 10.8%, and H04L transmission class, at 5.4%, suggest more room for claims framed around the compression or transmission mechanism itself rather than the genomic pipeline around it. Any filing strategy should also weigh receiving-office choice, since US, EPO and PCT together account for the bulk of the filings recorded here.
This Koninklijke Philips filing, published 2023-11-23, claims a method for storing a genomic dataset in a file structure paired with an information metadata structure. The metadata structure covers annotation tables with user permissions, analytics information for verifying data reproducibility, access history for traceability, and linkage information connecting the annotation table to the dataset. It is a data-structure and storage claim rather than a compression-algorithm claim, so it constrains genomic file architecture design more than it constrains a standalone codec.
Go past this page: query the whole sequence read compression algorithm patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Help us improve
Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.
This page